Anti-Diabetic Drug ‘Ayush-82’ to be commercialised

In Science and Technology
March 17, 2016

what is Ayush 82?

The National Research Development Corporation(NRDC) of the Department of Scientific & Industrial Research, Ministry of Science & Technology signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an ayurvedic formulation for prevention and management of Diabetes.

Now Kudos Laboratories India could commercialize this product under their trade name with due acknowledgement to CCRAS, Ministry of AYUSH, Government of India.

Did You Know?

There is an emerging global epidemic of diabetes that can be traced back to rapid increases in overweight, obesity and physical inactivity.
Total deaths from diabetes are projected to rise by more than 50% in the next 10 years. Most notably, they are projected to increase by over 80% in upper-middle income countries.
Type 1 diabetes is characterized by a lack of insulin production and type 2 diabetes results from the body’s ineffective use of insulin.
Type 2 diabetes is much more common than type 1 diabetes, and accounts for around 90% of all diabetes worldwide.
The third type of diabetes is gestational diabetes. This type is characterized by hyperglycaemia or raised blood sugar, which is first recognized during pregnancy.
Diabetes can be prevented. Thirty minutes of moderate-intensity physical activity on most days and a healthy diet can drastically reduce the risk of developing type 2 diabetes.